HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phenotypic characteristics of lewis lung carcinoma cells.

Abstract
We studied adhesive properties and physiological activity in vivo of cells from Lewis lung carcinoma and its metastases. These cells differed in tumorogenic activity and metastatic potential in the syngeneic system. In vivo non-metastasizing cells are characterized by a lower content of surface lectins to tetrasaccharides SiaLex [Neu5Aca2-3Galb1-4(Fuca1-3) GlcNAcb] and SiaLea [Neu5Aca2-3Galb1-3(Fuca1-4)GlcNAcb] and trisaccharide HSO3Lex [HSO32-3Galb1-4(Fuca1-3)GlcNAcb] compared to cells forming metastases in the syngeneic system. Metastatic cells with low tumorogenic activity weakly expressed lectins to disaccharide ligands 6-SiaLac [Neu5Aca2-6Galb1-4Glc], 6-HSO3LacNAc, and A-di [GalNAca 1-3Galb] and trisaccharides H-type 1 [Fuca1-2Galb1-3GlcNAc and Lex [Fuca1-3(Galb 1-4)GlcNAc] compared to cells that initiated tumor formation in the syngeneic system (similarly to transplanted tumors). We hypothesized that cell receptors to these carbohydrate determinates are involved in the development and growth of primary tumors, while lectins to SiaLex, SiaLea, and HSO3Lex play a role in the progress of tumor process and metastasizing.
AuthorsG P Gaenko, A M Kozlov, N S Saprykina, E B Dorotnikova, S V Khaidukov, Yu G Molotkovskii
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 134 Issue 4 Pg. 382-4 (Oct 2002) ISSN: 0007-4888 [Print] United States
PMID12533766 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Lectins
  • Ligands
  • Oligosaccharides
  • Trisaccharides
Topics
  • Animals
  • Carcinoma, Lewis Lung (metabolism, pathology, secondary)
  • Cell Adhesion
  • Lectins (metabolism)
  • Ligands
  • Mice
  • Neoplasm Metastasis
  • Neoplasm Transplantation
  • Oligosaccharides (metabolism)
  • Phenotype
  • Trisaccharides (metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: